阿布1020

押注新冠疫苗的企业仍未走出市场剧变的阴霾。 3月4日，艾美疫苗（6660.HK）发布的业绩预告显示，2023年净亏损可达到18.1亿元至19.9亿元，较2022年2.3亿元净亏损扩大了数倍。 巨亏的原因指向了市场行情变化——mRNA新冠疫苗子公司珠海丽凡达生物技术有限公司（下称“丽凡达生物”）的管线以及mRNA技术平台出现了大额的减值，预计减值损失的金额在16.5亿元至18亿元。 “鉴于新冠疫情在全世界范围内发生重大变化，本集团在2023年度结合产品研发进度、市场环境变化及销售预测等综合因素对收购控股子公司珠海丽凡达生物技术有限公司形成的无形资产及商誉计提减值损失，介乎人民币16.5亿元至18

Last week, Gold (XAU/USD) recorded minor gains and ended above the $2,030 mark. Economists at ANZ Bank analyze the yellow metal’s outlook. Fed officials warned patience is needed before they start cutting rates Gold managed to eke out a small weekly gain despite policymakers remaining hawkish.

The DXY Index shows losses, trading near the 103.05 area.Weekly Jobless Claims came in higher than expected.Markets still digesting Wednesday’s Fed decision and Powell's words. The US Dollar (USD) is currently trading at 103.05, with a declining trend, largely triggered by the release of soft labor